Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs HSBC Holdings plc (HSBC) Price & Performance

Adaptive Biotechnologies CorpTrade
HSBC Holdings plcTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs HSBC Holdings plc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while HSBC Holdings plc trades at $103.85 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 87.6× Adaptive Biotechnologies Corp's market cap, and HSBC Holdings plc pays a 3.63% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.

ADPTHSBC
Market Cap
$4.04B$353.82B
Sector
HealthTechnology
52-Week High
$25.45$107.86
52-Week Low
$12.30$63.84
Enterprise Value
$4.10B
Dividend Yield
3.63%

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About HSBC Holdings plc

HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.

Read more on HSBC